A potent and highly selective irreversible HER2 inhibitor for treating HER2-driven cancers

This is some text inside of a div block.

Publications

This is some text inside of a div block.

April 18, 2023

Media Contacts

Related announcements

View All

November 22, 2023

The Bio Report: A Company Betting Its Physics-Based AI Will Fuel a Quantum Leap in Drug Discovery

November 22, 2023

The Bio Report: A Company Betting Its Physics-Based AI Will Fuel a Quantum Leap in Drug Discovery

October 11, 2023

BIOS Builders #23 with Tom Miller

October 11, 2023

BIOS Builders #23 with Tom Miller

October 4, 2023

Fierce Biotech: Iambic Ups Rhythm in AI-enabled Race to Clinic, Revealing $100M Round and Nvidia Pact

October 4, 2023

Fierce Biotech: Iambic Ups Rhythm in AI-enabled Race to Clinic, Revealing $100M Round and Nvidia Pact